You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia

Showing 1 - 25 of 9,158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial (Dasatinib)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 20, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti Tim-3/CD123 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 4, 2023

Acute Myeloid Leukemia Trial in Antalya

Recruiting
  • Acute Myeloid Leukemia
    • Antalya, Turkey
      Antalya Training and Research Hospital
    Jul 29, 2023

    Patients With Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia, Adult
      • Freiburg, CA, Germany
        Medical Center- University of Freiburg
      Aug 4, 2023

      B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

      Recruiting
      • B-Cell Lymphoblastic Leukemia
      • Acute Lymphoblastic Leukemia
      • Tampa, Florida
        Moffitt Cancer Center
      Nov 28, 2023

      Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Loncastuximab Tesirine
      • (no location specified)
      Jul 24, 2023

      Enteral Nutrition in Children Treated for Acute Lymphoblastic

      Active, not recruiting
      • Leukemia, Lymphoblastic
      • enteral or parenteral nutritional support
      • Vandœuvre-lès-Nancy, France
        CHRU Nancy
      Oct 26, 2023

      Acute Myeloid Leukemia Trial (ABBV-787)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • (no location specified)
      Sep 29, 2023

      Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • CD123 targeted CAR-NK cells
      • Taiyuan, Shanxi, China
        Shanxi Bethune Hospital
      Aug 28, 2023

      Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

      Recruiting
      • Acute Myeloid Leukemia Refractory
      • Lyon, France
        Centre Léon Bérard
      Nov 30, 2023

      H19 in Acute Lymphoblastic Leukemia.

      Not yet recruiting
      • Acute Lymphoid Leukemia
        • (no location specified)
        Jul 11, 2023

        Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

        Not yet recruiting
        • Acute Myeloid Leukemia, in Relapse
        • Acute Myeloid Leukemia Refractory
        • (no location specified)
        Nov 9, 2023

        AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

        Not yet recruiting
        • AML
        • +11 more
        • (no location specified)
        Aug 14, 2023

        Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

        Not yet recruiting
        • Acute Lymphoblastic Leukemia, in Relapse
        • Acute Lymphoblastic Leukemia With Failed Remission
        • São Paulo, SP, Brazil
          Instituto do Cancer do Estado de Sao Paulo
        Sep 12, 2023

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • (no location specified)
        Nov 22, 2023

        A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

        Not yet recruiting
        • C-KIT Mutation
          • (no location specified)
          Nov 2, 2023

          Acute Myeloid Leukemia Trial in Beijing (N-acetyl-L-cysteine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Beijing, Beijing, China
            Yuan Kong
          Sep 4, 2023

          Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Oral azacitidine
          • Seoul, Korea, Republic of
            Bristol-Myers Squibb YH
          Oct 3, 2023

          Lymphoblastic Leukemia Trial in Palo Alto (Dasatinib)

          Not yet recruiting
          • Lymphoblastic Leukemia
          • Palo Alto, California
            Stanford University
          Aug 14, 2023

          Leukemia Trial in Alexandria (Peppermint Inhalation, Swedish Massage)

          Completed
          • Leukemia
          • Peppermint Inhalation
          • Swedish Massage
          • Alexandria, Egypt
            Eman Arafa Badr
          Oct 17, 2023

          The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding

          Completed
          • Leukemia, Acute
            • (no location specified)
            Jul 23, 2023

            Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

            Not yet recruiting
            • Chronic Myelogenous Leukemia - Chronic Phase
            • APN and medical management
            • +3 more
            • Avignon, Provence-Alpes-Côte d'Azur, France
              Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
            Oct 13, 2023

            Chronic Lymphocytic Leukemia Patients

            Not yet recruiting
            • Chronic Lymphocytic Leukemia
              • San Francisco, California
                Power Life Sciences
              Jun 2, 2023

              Asciminib RMP Study

              Not yet recruiting
              • Chronic Myeloid Leukemia
              • Asciminib
              • (no location specified)
              Jul 5, 2023

              T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

              Not yet recruiting
              • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
              • CD7-CART01
              • (no location specified)
              Sep 26, 2023